Search results for "Bronchospasm"

showing 4 items of 4 documents

Effectiveness of oral N -acetylcysteine in a rat experimental model of asthma

2002

Oxidative stress appears to be relevant to asthma pathogenesis. Therefore, the effectiveness of the antioxidant N -acetylcysteine was examined on antigen-induced pulmonary responses in sensitized Brown-Norway rats. N -acetylcysteine (oral, 1 mmol kg(-1)per day for 7 days before challenge) did not reduce the immediate bronchospasm that followed aerosol antigen exposure but prevented airway hyperreactivity to 5-hydroxytryptamine at 24 h after antigen challenge, and reduced the eosinophils (from 0.178 +/- 0.038 in the absence to 0.064 +/- 0.020 x10(6)cells ml(-1)in the presence of N -acetylcysteine;P< 0.05), and Evans blue dye extravasation in bronchoalveolar lavage fluid. Taurine levels in br…

MaleTaurineBronchoconstrictionLung injuryPharmacologyBronchospasmAcetylcysteinechemistry.chemical_compoundRats Inbred BNmedicineAnimalsAntigensEvans BluePharmacologyDose-Response Relationship Drugmedicine.diagnostic_testbusiness.industryFree Radical Scavengersrespiratory systemAsthmaExtravasationAcetylcysteineRatsrespiratory tract diseasesEosinophilsDisease Models AnimalDose–response relationshipBronchoalveolar lavagechemistryImmunologymedicine.symptombusinessBronchoalveolar Lavage FluidEvans BlueExtravasation of Diagnostic and Therapeutic Materialsmedicine.drugPharmacological Research
researchProduct

Effects of bemiparin on airway responses to antigen in sensitized Brown-Norway rats.

2004

Heparins have demonstrated activity in asthma. The effects of bemiparin, a low molecular weight heparin, were examined on antigen-induced responses in sensitized Brown-Norway rats. Inhaled bemiparin (1 mg/ml) reduced the acute bronchospasm produced by aerosol antigen, prevented airway hyperresponsiveness to 5-hydroxytryptamine postantigen exposure, and reduced the eosinophil count (from 0.205+/-0.062 to 0.054+/-0.016 x 10(6) cells/ml in antigen and antigen+bemiparin groups, respectively; P<0.05), eosinophil peroxidase activity, and proteins in the bronchoalveolar lavage fluid (BALF), as well as the transiently augmented mucin Muc5ac expression. Hyperresponsiveness to adenosine was not affec…

Malemedicine.drug_classLow molecular weight heparinPharmacologyFondaparinuxBronchospasmAntigenRats Inbred BNmedicineAnimalsAntigensPharmacologymedicine.diagnostic_testbusiness.industryMucinHeparinrespiratory systemEosinophilHeparin Low-Molecular-WeightAsthmaRatsBronchoalveolar lavagemedicine.anatomical_structureImmunologyImmunizationmedicine.symptombusinessmedicine.drugEuropean journal of pharmacology
researchProduct

Severe Brochostenosis by Oral Propafenone Immediately After Commencing Treatment

2011

Propafenone is a membrane-stabilizing agent belonging to a subgroup of the Vaughan Williams class I antidysrhythmic agents, structurally resembling propranolol and characterized by weaker beta-blocking activity. Despite respiratory complications having been reported as examples of side effects, very few reports have been published in the literature.We describe the case of an elderly woman with a history of hypertension and allergy to Parietaria, grass, olive, mites, and with periodic asthmatic manifestations, for whom the administration of oral propafenone for recurrent supraventricular dysrhythmia was associated with the sudden onset of severe bronchostenosis.A 78-year-old woman was freque…

Pharmacologybusiness.industryGeneral MedicinePropafenonemedicine.diseaseRhonchipropafenone broncostenosisHypoxemiaBronchospasmAnesthesiamedicineSalbutamolPharmacology (medical)Medical historyRespiratory functionSupraventricular tachycardiamedicine.symptombusinessmedicine.drugAmerican Journal of Therapeutics
researchProduct

Anaphylaktoide Reaktion auf ein nichtionisches Röntgenkontrastmittel in Allgemeinanästhesie

1990

The occurrence of adverse reactions is decreasing since the introduction of non-ionic contrast media. Anaphylactoid reactions during general anaesthesia are rare and hitherto only documented with the administration of ionic compounds. We report an episode of hypotension, tachycardia, bronchospasm and urticaria following application of a non-ionic contrast medium (Iopamidol) during isoflurane anaesthesia. We conclude that a combinent use of anaesthesia and non-ionic contrast media does not guaranty protection from anaphylactoid reactions to iodinated radiopaque compounds.

Tachycardiabusiness.industryGeneral MedicineCritical Care and Intensive Care MedicineIopamidolIsoflurane anaesthesiaBronchospasmContrast mediumAnesthesiology and Pain MedicineIsofluraneAnesthesiaEmergency MedicinemedicineGeneral anaesthesiaAnaphylactoid reactionsmedicine.symptombusinessmedicine.drugAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
researchProduct